Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segm. Track Jubilant Ingrevia Limited's live NSE:JUBLINGREA share price โน752.80 (+2.42%), market cap โนโน119B, P/E 38.8. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Basic Materials sector outlook for JUBLINGREA โ real-time NSE India stock intelligence.
Jubilant Ingrevia Limited
03 August 2026 ยทNSE
Market Cap
โน119B
PE Ratio
38.8
Dividend
0.68%
AI Score
49/100
Open
โน739.90
High
โน760.50
Low
โน734.05
Prev. Close
โน735.00
52W High
โน795.00
52W Low
โน537.30
Jubilant Ingrevia Limited engages in life science products and solutions in India, the United States, Europe, China and internationally. The company operates in three segments: Specialty Chemicals, Nutrition & Health Solutions, and Chemical Intermediates. The Specialty Chemicals segment offers bio-pyridine and -picolines, fine chemicals, agro chemicals, custom development and manufacturing services, and microbial control solutions. The Nutrition & Health Solutions segment provides nutrition and health ingredients; and animal and human nutrition health solutions. The Chemical intermediates segm
Key Takeaway
Jubilant Ingrevia Limited is rated strong buy with a P/E of 38.8x โ understand the valuation context before sizing a position.
โ Recommended
Ask AI: Is Jubilant Ingrevia Limited fairly valued right now?
Because a P/E of 38.8x needs to be compared against sector peers and growth expectations to be meaningful.
Continue Research
View events affecting Jubilant Ingrevia Limited
Because the investment case must account for macro and company-specific developments โ events reveal the 'why' behind price moves.
Trace sector ripple effects
Because Basic Materials moves create upstream and downstream implications that affect the entire thesis.
Intelligence Path
Growth
Govt Exposure
Policy Dependence
Execution Quality
News Sensitivity
Debt Strength
1,289 Cr
Revenue
106 Cr
Net Profit
0%
ROE
0%
ROCE
19.42
EPS
| โน in Crore | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|
| Revenue | 4,740 | 4,100 | 4,124 | 4,345 | 4,524 |
| Net Profit | 307 | 183 | 251 | 278 | 314 |
| ROE (%) | โ | โ | โ | 0.0% | 0.0% |
| EPS (โน) | โ | โ | โ | 19.42 | 19.42 |
| Debt/Equity | โ | โ | โ | 25.3 | 25.3 |